BTK Inhibitors in the Treatment of MS MStranslate December 12, 2023 Clinical Trials, Research, Treatments What is Bruton’s Tyrosine Kinase (BTK)? Bruton’s Tyrosine Kinase, or BTK, is an enzyme in the body that plays a role in the activity of B cells. B cells, which are important cells in the immune system,...
Clemastine Repairs Damage In Multiple Sclerosis MStranslate July 4, 2023 Clinical Trials, Neuroimaging, Remyelination Research Summary: MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial Remyelination or myelin repair is the next big step in the treatment of multiple sclerosis. ...
Research Reflections: Siponimod Trial Results MStranslate November 21, 2019 Clinical Trials, Research, Treatments 1 Comment In April 2018, we published the below video to our Facebook page, exploring and discussing the results of the Phase III trial of Mayzent (siponimod). With this therapy recently approved for the treatment of...
Multiple Sclerosis Clinical Trial Update: Laquinimod MStranslate May 9, 2017 Clinical Trials, Laquinimod, Research What is laquinimod? Laquinimod is a once-daily oral medication that has been developed and tested for the treatment of relapsing-remitting multiple sclerosis (RRMS) and primary progressive MS (PPMS). The...
High-dose Biotin Clinical Trial Results MStranslate September 13, 2016 Biotin, Clinical Trials, Research, Treatments 1 Comment Research Summary: MD1003 (high-dose biotin) for the treatment of multiple sclerosis: A randomised, double-blind, placebo-controlled study The background Whilst many treatments are now available for...
MOMENTUM Phase II Trial Results MStranslate August 22, 2016 Clinical Trials, Fingolimod, Research The background Fingolimod was approved in 2010 and became the first oral drug for the treatment of relapsing-remitting MS (RRMS). It has proven to be beneficial for many people with MS and works by...
Multiple Sclerosis Research: Dr Leigh Charvet MStranslate May 9, 2016 AAN, Clinical Trials, Cognition, Conferences, Research, Symptoms INTERVIEW WITH DR LEIGH CHARVET – NYU LANGONE MULTIPLE SCLEROSIS COMPREHENSIVE CARE CENTER BD: Brett Drummond, MStranslate LC: Dr. Leigh Charvet, NYU Langone Multiple Sclerosis Comprehensive Care...
Multiple Sclerosis Research: Dr Christian Gruber MStranslate May 9, 2016 Clinical Trials, Research, Treatments, Videos 4 Comments INTERVIEW WITH DR CHRISTIAN GRUBER – MEDICAL UNIVERSITY OF VIENNA AND UNIVERSITY OF QUEENSLAND BD: Brett Drummond, MStranslate CG: Dr. Christian Gruber, Medical University of Vienna & University...
Antihistamine may stimulate myelin repair MStranslate April 13, 2016 Clinical Trials, Remyelination, Research, Treatments 1 Comment A small, Phase II clinical trial has shown that a common over the counter antihistamine, called clemastine fumarate, has the ability to partially reverse damage to the optic nerve in people with multiple...
Clinical Trial: MIS416 for Secondary Progressive MS MStranslate October 8, 2015 Clinical Trials, Research A detailed look at the development of Innate Immunotherapeutics' potential Secondary Progressive MS treatment,...
